檢索結果 - Lorenza Rimassa

Refine Results
  1. 1
    Navigating the new landscape of second‐line treatment in advanced hepatocellular carcinoma

    Navigating the new landscape of second‐line treatment in advanced hepatocellular carcinoma 由 Lorenza Rimassa, Marcus‐Alexander Wörns

    出版 2020
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    <p>Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date</p>

    <p>Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date</p> 由 Nicola Personeni, Tiziana Pressiani, Lorenza Rimassa

    出版 2019
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Systemic Treatment Options in Hepatocellular Carcinoma

    Systemic Treatment Options in Hepatocellular Carcinoma 由 Lorenza Rimassa, Tiziana Pressiani, Philippe Merle

    出版 2019
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Molecular therapies for HCC: Looking outside the box

    Molecular therapies for HCC: Looking outside the box 由 Sandrine Faivre, Lorenza Rimassa, Richard S. Finn

    出版 2020
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  5. 5
    Combination immunotherapy for hepatocellular carcinoma

    Combination immunotherapy for hepatocellular carcinoma 由 Lorenza Rimassa, Richard S. Finn, Bruno Sangro

    出版 2023
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  6. 6
    Management of adverse events associated with tyrosine kinase inhibitors: Improving outcomes for patients with hepatocellular carcinoma

    Management of adverse events associated with tyrosine kinase inhibitors: Improving outcomes for patients with hepatocellular carcinoma 由 Lorenza Rimassa, Romano Danesi, Tiziana Pressiani, Philippe Merle

    出版 2019
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  7. 7
    Hepatocellular Carcinoma: Therapeutic Guidelines and Medical Treatment

    Hepatocellular Carcinoma: Therapeutic Guidelines and Medical Treatment 由 Masatoshi Kudo, Franco Trevisani, Ghassan K. Abou‐Alfa, Lorenza Rimassa

    出版 2016
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  8. 8
    Pancreatic Ductal Adenocarcinoma and Immune Checkpoint Inhibitors: The Gray Curtain of Immunotherapy and Spikes of Lights

    Pancreatic Ductal Adenocarcinoma and Immune Checkpoint Inhibitors: The Gray Curtain of Immunotherapy and Spikes of Lights 由 Rita Balsano, Valentina Zanuso, Angelo Pirozzi, Lorenza Rimassa, Silvia Bozzarelli

    出版 2023
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  9. 9
    Systemic treatment of HCC in special populations

    Systemic treatment of HCC in special populations 由 Lorenza Rimassa, Nicola Personeni, Carolin Czauderna, Friedrich Foerster, Peter R. Galle

    出版 2020
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  10. 10
    Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab

    Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab 由 Chiun Hsu, Lorenza Rimassa, Hui‐Chuan Sun, Arndt Vogel, Ahmed O. Kaseb

    出版 2021
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  11. 11
    ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma

    ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma 由 Coşkun Özer Demirtas, Antonio D’Alessio, Lorenza Rimassa, Rohini Sharma, David J. Pinato

    出版 2021
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  12. 12
    Role of molecular genetics in the clinical management of cholangiocarcinoma

    Role of molecular genetics in the clinical management of cholangiocarcinoma 由 Nicola Normanno, Erika Martinelli, Davide Melisi, Carmine Pinto, Lorenza Rimassa, Daniele Santini, Aldo Scarpa

    出版 2022
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  13. 13
    Immunotherapy in hepatocellular carcinoma: how will it reshape treatment sequencing?

    Immunotherapy in hepatocellular carcinoma: how will it reshape treatment sequencing? 由 Antonella Cammarota, Valentina Zanuso, Giulia Francesca Manfredi, Ravindhi Murphy, David J. Pinato, Lorenza Rimassa

    出版 2023
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  14. 14
    Cabozantinib in combination with atezolizumab versus sorafenib in treatment-naive advanced hepatocellular carcinoma: COSMIC-312 Phase III study design

    Cabozantinib in combination with atezolizumab versus sorafenib in treatment-naive advanced hepatocellular carcinoma: COSMIC-312 Phase III study design 由 Robin Kate Kelley, Jennifer Oliver, Saswati Hazra, Fawzi Benzaghou, Thomas Yau, Ann‐Lii Cheng, Lorenza Rimassa

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Practical guidelines for molecular testing of cholangiocarcinoma in clinical practice: Italian experts’ position paper

    Practical guidelines for molecular testing of cholangiocarcinoma in clinical practice: Italian experts’ position paper 由 Matteo Fassan, Valentina Angerilli, Nicola Normanno, Giancarlo Pruneri, Antonio Marchetti, Federica Grillo, Giuseppe Tonini, Aldo Scarpa, Lorenza Rimassa

    出版 2024
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Navigating the landscape of liver cancer management: Study designs in clinical trials and clinical practice

    Navigating the landscape of liver cancer management: Study designs in clinical trials and clinical practice 由 Giuseppe Cabibbo, Ciro Celsa, Lorenza Rimassa, Ferrán Torres, Jordi Rimola, Roman Kloeckner, Jordi Bruix, Calogero Cammà, María Reig

    出版 2024
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options

    Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options 由 Nicola Personeni, Ana Lleó, Tiziana Pressiani, Francesca Colapietro, Mark R. Openshaw, Chara Stavraka, Athanasios Pouptsis, David J. Pinato, Lorenza Rimassa

    出版 2020
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  18. 18
    5-fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors

    5-fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors 由 Emilio Bajetta, Lorenza Rimassa, Carlo Carnaghi, Ettore Seregni, Leonardo Ferrari, Maria Di Bartolomeo, Enrico Regalia, Antonio Cassata, Giuseppe Procopio, Luigi Mariani

    出版 1998
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Immune-based therapies for hepatocellular carcinoma

    Immune-based therapies for hepatocellular carcinoma 由 David J. Pinato, Nadia Guerra, Petros Fessas, Ravindhi Murphy, Takashi Mineo, Francesco Mauri, Sujit Mukherjee, Mark Thursz, Ching Ngar Wong, Rohini Sharma, Lorenza Rimassa

    出版 2020
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  20. 20
    Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up 由 Arndt Vogel, John Bridgewater, Julien Edeline, Robin Kate Kelley, Heinz‐Josef Klümpen, David Malka, John Primrose, Lorenza Rimassa, Albrecht Stenzinger, Juan W. Valle, Michel Ducreux

    出版 2022
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: